Retinal Vein Occlusion Treatments
Find Retinal Vein Occlusion Treatments
Brand Name
Ahzantive
Generic Name
Aflibercept-Mrbb
View Brand Information FDA approval date: June 01, 2024
Classification: Vascular Endothelial Growth Factor Inhibitor
Form: Injection
What is Ahzantive (Aflibercept-Mrbb)?
These highlights do not include all the information needed to use AHZANTIVE safely and effectively. See full prescribing information for AHZANTIVE. Initial U.S. Approval: 2024 1 INDICATIONS AND USAGE AHZANTIVE is indicated for the treatment of.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment